Description: This panel will discuss the current status of NAIC activities with respect to risk-based capital RBC. The potential impact on financial reporting with respect to health products, specifically, indemnity, HMO, disability, and nontraditional products will also be discussed. From the Record of the Society of Actuaries, Vol.21, No. 4a.

Description: This panel discussion session examines the marketing and pricing considerations of group insurance in the 1980's.

Description: This session from the 1984 SOA Salt Lake City Meeting discusses health insurance including the topics of the Washington loss ratio report, problems which lead to regulatory difficulties later on, claims monitoring, setting claim reserves and pricing individual health policies.

Description: This session from the 1992 Valuation Actuary Symposium explores the new reserve adequacy provision for disability income that requires reserves be adequate in light of the assets held by the company with respect to those reserves.

Description: 1999 Valuation Actuary Symposium, Los Angeles. The panelists discussed the RBC formula treatment for health products for the life and the health organizations and the managed care organizations. They also covered what the health terms look like in the casualty RBC formula.

Description: This session from the 1981 SOA Spring Meeting focused on Disability Income Marketing Approaches for group disability, multiple employer trusts and individual disability. The following factors that influenced the market place were reviewed: high inflation, high unemployment and regulations. From Record of Society of Actuaries, Vol. 7, No. 3.

Description: This panel discussion is about claim reserves. It focused on: 1. Review of methods and statutory requirements in the establishment of claim reserves for property and casualty, life and health insurance. 2. Discussion of different approaches in casualty and life blanks e.g., incurred but not reported reserves.

Description: 1992 SOA Regional Meeting, Chicago. This discussion is about direct marketing growth in the 1980s, sustaining the growth in the 1990s, regulatory constraints in the 1990s, impact of continuing production cost increases, new product designs, and declining response rate.

Description: This 1980 session is about effect of government actions and consumerism on product design and pricing. Areas addressed: 1. What have been the most important regulatory and consumerist actions in the past decade as related to products, their marketing and the overall operation of a life insurance company? 2. What will be the most important actions in these arenas in the next decade? 3. What specific impact have these regulatory and consumer actions had on companies in the past decade and will they have in the coming decade? 4. What true value has accrued to consumers and the public because of these actions, and what impact will they have in the next decade? 5. Is there an acceptable relationship between the value of these benefits and the cost to the companies of providing them?

Description: A discussion of the Brazilian Health Industry